Study of Thymosin Beta 4 in Patients With Pressure Ulcers

NCT00382174 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Pressure Ulcers

Interventions

DRUG: Placebo
DRUG: Thymosin Beta 4

Sponsor

RegeneRx Biopharmaceuticals, Inc.